{"count": 2, "results": [{"_id": "27391065", "pmid": 27391065, "pmcid": "PMC5226535", "title": "Metformin as a new anti-cancer drug in adrenocortical carcinoma", "journal": "Oncotarget", "authors": ["Poli G", "Cantini G", "Armignacco R", "Fucci R", "Santi R", "Canu L", "Nesi G", "Mannelli M", "Luconi M"], "date": "2016-08-02T00:00:00Z", "doi": "10.18632/oncotarget.10421", "meta_date_publication": "2016 Aug 2", "meta_volume": "7", "meta_issue": "31", "meta_pages": "49636-49648", "score": 50051.977, "text_hl": "@<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Metformin@@@ interferes with the proliferative autocrine loop of @GENE_IGF2 @GENE_3481 @@@IGF2@@@/@GENE_IGF1R @GENE_16001 @@@IGF-1R@@@, which supports @<m>DISEASE_Adrenal_Gland_Neoplasms</m> @DISEASE_MESH:D000310 @@@adrenal cancer@@@ growth. ", "citations": {"NLM": "Poli G, Cantini G, Armignacco R, Fucci R, Santi R, Canu L, Nesi G, Mannelli M, Luconi M. Metformin as a new anti-cancer drug in adrenocortical carcinoma Oncotarget. 2016 Aug 2;7(31):49636-49648. PMID: 27391065", "BibTeX": "@article{27391065, title={Metformin as a new anti-cancer drug in adrenocortical carcinoma}, author={Poli G and Cantini G and Armignacco R and Fucci R and Santi R and Canu L and Nesi G and Mannelli M and Luconi M}, journal={Oncotarget}, volume={7}, number={31}, pages={49636-49648}}"}}, {"_id": "31320975", "pmid": 31320975, "title": "Efficacy of Metformin in the Treatment of Acne in Women with Polycystic Ovarian Syndrome: A Newer Approach to Acne Therapy.", "journal": "J Clin Aesthet Dermatol", "authors": ["Sharma S", "Mathur DK", "Paliwal V", "Bhargava P"], "date": "2019-05-01T00:00:00Z", "meta_date_publication": "2019 May", "meta_volume": "12", "meta_issue": "5", "meta_pages": "34-38", "score": 50047.62, "text_hl": "Introduction: @DISEASE_Acne_Vulgaris @DISEASE_MESH:D000152 @@@Acne vulgaris@@@ is a chronic @DISEASE_Inflammation @DISEASE_MESH:D007249 @@@inflammatory@@@ disorder of the pilosebaceous units and has been associated with @DISEASE_Hyperandrogenism @DISEASE_MESH:D017588 @@@hyperandrogenism@@@, which, in @SPECIES_9606 @@@women@@@, is most commonly caused by @DISEASE_Polycystic_Ovary_Syndrome @DISEASE_MESH:D011085 @@@polycystic ovary syndrome@@@ (@DISEASE_Polycystic_Ovary_Syndrome @DISEASE_MESH:D011085 @@@PCOS@@@). @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Metformin@@@ treatment can correct ovarian and functional @<m>DISEASE_Adrenal_Gland_Neoplasms</m> @DISEASE_MESH:D000310 @@@adrenal@@@ @DISEASE_Hyperandrogenism @DISEASE_MESH:D017588 @@@hyperandrogenism@@@ in adolescents with @DISEASE_Polycystic_Ovary_Syndrome @DISEASE_MESH:D011085 @@@PCOS@@@. ", "citations": {"NLM": "Sharma S, Mathur DK, Paliwal V, Bhargava P. Efficacy of Metformin in the Treatment of Acne in Women with Polycystic Ovarian Syndrome: A Newer Approach to Acne Therapy. J Clin Aesthet Dermatol. 2019 May;12(5):34-38. PMID: 31320975", "BibTeX": "@article{31320975, title={Efficacy of Metformin in the Treatment of Acne in Women with Polycystic Ovarian Syndrome: A Newer Approach to Acne Therapy.}, author={Sharma S and Mathur DK and Paliwal V and Bhargava P}, journal={J Clin Aesthet Dermatol}, volume={12}, number={5}, pages={34-38}}"}}]}